$150 Million

Theravance Biopharma

At-the-market Offering

Theravance Biopharma
Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines. The Company’s focus areas for research are inflammation and immunology.